Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Total Non-Current Liabilities (2016 - 2025)

AtriCure (ATRC) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $154.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 5.27% to $154.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $154.9 million, a 5.27% increase, with the full-year FY2025 number at $154.9 million, up 5.27% from a year prior.
  • Total Non-Current Liabilities was $154.9 million for Q4 2025 at AtriCure, up from $151.6 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $154.9 million in Q4 2025 to a low of $118.7 million in Q1 2021.
  • A 5-year average of $134.6 million and a median of $132.3 million in 2023 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: grew 17.41% in 2021, then fell 2.2% in 2022.
  • AtriCure's Total Non-Current Liabilities stood at $130.3 million in 2021, then decreased by 2.2% to $127.5 million in 2022, then increased by 14.95% to $146.5 million in 2023, then rose by 0.42% to $147.1 million in 2024, then increased by 5.27% to $154.9 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Total Non-Current Liabilities are $154.9 million (Q4 2025), $151.6 million (Q3 2025), and $143.2 million (Q2 2025).